NEW HAVEN, Conn., Feb. 9, 2011 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of treatments for the most challenging infectious diseases, today announced that Michael D. Kishbauch, President and Chief Executive Officer, will be presenting a company overview at the upcoming investor conferences:
- 13th Annual BIO CEO & Investor Conference on Tuesday, February 15, 2011 at 11:30 a.m. ET at the Waldorf=Astoria in New York City;
- Leerink Swann Hot Topics and Therapeutics Roundtable Conference on Wednesday, February 16, 2011 at 2:40 p.m. ET at the Roosevelt Hotel in New York City; and
- 31st Annual Cowen & Company Healthcare Conference on March 7, 2011 at 2:30 p.m. at the Marriott Copley Place in Boston.
CONTACT: Mary Kay Fenton Achillion Pharmaceuticals, Inc. Tel. (203) 624-7000 firstname.lastname@example.org Investor Relations: Anne Marie Fields Lippert/Heilshorn & Associates, Inc. Tel. (212) 838-3777 email@example.com